Global Targeted Drug ROS1 Inhibitors for NSCLC Market Research Report 2025

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Crizotinib
1.2.3 Lorlatinib
1.2.4 Entrectinib
1.2.5 Others
1.3 Market by Application
1.3.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Squamous Cell Carcinoma of NSCLC
1.3.3 Adenocarcinoma of NSCLC
1.3.4 Large Cell Carcinoma of NSCLC
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Perspective (2020-2031)
2.2 Global Targeted Drug ROS1 Inhibitors for NSCLC Growth Trends by Region
2.2.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Targeted Drug ROS1 Inhibitors for NSCLC Historic Market Size by Region (2020-2025)
2.2.3 Targeted Drug ROS1 Inhibitors for NSCLC Forecasted Market Size by Region (2026-2031)
2.3 Targeted Drug ROS1 Inhibitors for NSCLC Market Dynamics
2.3.1 Targeted Drug ROS1 Inhibitors for NSCLC Industry Trends
2.3.2 Targeted Drug ROS1 Inhibitors for NSCLC Market Drivers
2.3.3 Targeted Drug ROS1 Inhibitors for NSCLC Market Challenges
2.3.4 Targeted Drug ROS1 Inhibitors for NSCLC Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Drug ROS1 Inhibitors for NSCLC Players by Revenue
3.1.1 Global Top Targeted Drug ROS1 Inhibitors for NSCLC Players by Revenue (2020-2025)
3.1.2 Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Market Share by Players (2020-2025)
3.2 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Targeted Drug ROS1 Inhibitors for NSCLC Revenue
3.4 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Concentration Ratio
3.4.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Drug ROS1 Inhibitors for NSCLC Revenue in 2024
3.5 Global Key Players of Targeted Drug ROS1 Inhibitors for NSCLC Head office and Area Served
3.6 Global Key Players of Targeted Drug ROS1 Inhibitors for NSCLC, Product and Application
3.7 Global Key Players of Targeted Drug ROS1 Inhibitors for NSCLC, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Drug ROS1 Inhibitors for NSCLC Breakdown Data by Type
4.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Historic Market Size by Type (2020-2025)
4.2 Global Targeted Drug ROS1 Inhibitors for NSCLC Forecasted Market Size by Type (2026-2031)
5 Targeted Drug ROS1 Inhibitors for NSCLC Breakdown Data by Application
5.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Historic Market Size by Application (2020-2025)
5.2 Global Targeted Drug ROS1 Inhibitors for NSCLC Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2020-2031)
6.2 North America Targeted Drug ROS1 Inhibitors for NSCLC Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2020-2025)
6.4 North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2020-2031)
7.2 Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2020-2025)
7.4 Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2020-2031)
8.2 Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Region (2020-2025)
8.4 Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2020-2031)
9.2 Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2020-2025)
9.4 Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2020-2031)
10.2 Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2020-2025)
10.4 Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Targeted Drug ROS1 Inhibitors for NSCLC Introduction
11.1.4 Roche Revenue in Targeted Drug ROS1 Inhibitors for NSCLC Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Targeted Drug ROS1 Inhibitors for NSCLC Introduction
11.2.4 Pfizer Revenue in Targeted Drug ROS1 Inhibitors for NSCLC Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Beacon Pharma Limited
11.3.1 Beacon Pharma Limited Company Details
11.3.2 Beacon Pharma Limited Business Overview
11.3.3 Beacon Pharma Limited Targeted Drug ROS1 Inhibitors for NSCLC Introduction
11.3.4 Beacon Pharma Limited Revenue in Targeted Drug ROS1 Inhibitors for NSCLC Business (2020-2025)
11.3.5 Beacon Pharma Limited Recent Development
11.4 Drug International Limted
11.4.1 Drug International Limted Company Details
11.4.2 Drug International Limted Business Overview
11.4.3 Drug International Limted Targeted Drug ROS1 Inhibitors for NSCLC Introduction
11.4.4 Drug International Limted Revenue in Targeted Drug ROS1 Inhibitors for NSCLC Business (2020-2025)
11.4.5 Drug International Limted Recent Development
11.5 Incepta Pharmaceuticals
11.5.1 Incepta Pharmaceuticals Company Details
11.5.2 Incepta Pharmaceuticals Business Overview
11.5.3 Incepta Pharmaceuticals Targeted Drug ROS1 Inhibitors for NSCLC Introduction
11.5.4 Incepta Pharmaceuticals Revenue in Targeted Drug ROS1 Inhibitors for NSCLC Business (2020-2025)
11.5.5 Incepta Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Crizotinib
Table 3. Key Players of Lorlatinib
Table 4. Key Players of Entrectinib
Table 5. Key Players of Others
Table 6. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Region (2020-2025)
Table 10. Global Targeted Drug ROS1 Inhibitors for NSCLC Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Region (2026-2031)
Table 12. Targeted Drug ROS1 Inhibitors for NSCLC Market Trends
Table 13. Targeted Drug ROS1 Inhibitors for NSCLC Market Drivers
Table 14. Targeted Drug ROS1 Inhibitors for NSCLC Market Challenges
Table 15. Targeted Drug ROS1 Inhibitors for NSCLC Market Restraints
Table 16. Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Players (2020-2025)
Table 18. Global Top Targeted Drug ROS1 Inhibitors for NSCLC Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drug ROS1 Inhibitors for NSCLC as of 2024)
Table 19. Ranking of Global Top Targeted Drug ROS1 Inhibitors for NSCLC Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Targeted Drug ROS1 Inhibitors for NSCLC Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Targeted Drug ROS1 Inhibitors for NSCLC, Headquarters and Area Served
Table 22. Global Key Players of Targeted Drug ROS1 Inhibitors for NSCLC, Product and Application
Table 23. Global Key Players of Targeted Drug ROS1 Inhibitors for NSCLC, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Market Share by Type (2020-2025)
Table 27. Global Targeted Drug ROS1 Inhibitors for NSCLC Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Market Share by Type (2026-2031)
Table 29. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Market Share by Application (2020-2025)
Table 31. Global Targeted Drug ROS1 Inhibitors for NSCLC Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Market Share by Application (2026-2031)
Table 33. North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2026-2031) & (US$ Million)
Table 48. Roche Company Details
Table 49. Roche Business Overview
Table 50. Roche Targeted Drug ROS1 Inhibitors for NSCLC Product
Table 51. Roche Revenue in Targeted Drug ROS1 Inhibitors for NSCLC Business (2020-2025) & (US$ Million)
Table 52. Roche Recent Development
Table 53. Pfizer Company Details
Table 54. Pfizer Business Overview
Table 55. Pfizer Targeted Drug ROS1 Inhibitors for NSCLC Product
Table 56. Pfizer Revenue in Targeted Drug ROS1 Inhibitors for NSCLC Business (2020-2025) & (US$ Million)
Table 57. Pfizer Recent Development
Table 58. Beacon Pharma Limited Company Details
Table 59. Beacon Pharma Limited Business Overview
Table 60. Beacon Pharma Limited Targeted Drug ROS1 Inhibitors for NSCLC Product
Table 61. Beacon Pharma Limited Revenue in Targeted Drug ROS1 Inhibitors for NSCLC Business (2020-2025) & (US$ Million)
Table 62. Beacon Pharma Limited Recent Development
Table 63. Drug International Limted Company Details
Table 64. Drug International Limted Business Overview
Table 65. Drug International Limted Targeted Drug ROS1 Inhibitors for NSCLC Product
Table 66. Drug International Limted Revenue in Targeted Drug ROS1 Inhibitors for NSCLC Business (2020-2025) & (US$ Million)
Table 67. Drug International Limted Recent Development
Table 68. Incepta Pharmaceuticals Company Details
Table 69. Incepta Pharmaceuticals Business Overview
Table 70. Incepta Pharmaceuticals Targeted Drug ROS1 Inhibitors for NSCLC Product
Table 71. Incepta Pharmaceuticals Revenue in Targeted Drug ROS1 Inhibitors for NSCLC Business (2020-2025) & (US$ Million)
Table 72. Incepta Pharmaceuticals Recent Development
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
Table 76. Authors List of This Report


List of Figures
Figure 1. Targeted Drug ROS1 Inhibitors for NSCLC Picture
Figure 2. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Type: 2024 VS 2031
Figure 4. Crizotinib Features
Figure 5. Lorlatinib Features
Figure 6. Entrectinib Features
Figure 7. Others Features
Figure 8. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Application: 2024 VS 2031
Figure 10. Squamous Cell Carcinoma of NSCLC Case Studies
Figure 11. Adenocarcinoma of NSCLC Case Studies
Figure 12. Large Cell Carcinoma of NSCLC Case Studies
Figure 13. Targeted Drug ROS1 Inhibitors for NSCLC Report Years Considered
Figure 14. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Region: 2024 VS 2031
Figure 17. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Players in 2024
Figure 18. Global Top Targeted Drug ROS1 Inhibitors for NSCLC Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drug ROS1 Inhibitors for NSCLC as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Targeted Drug ROS1 Inhibitors for NSCLC Revenue in 2024
Figure 20. North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Country (2020-2031)
Figure 22. United States Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Country (2020-2031)
Figure 26. Germany Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Region (2020-2031)
Figure 34. China Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Country (2020-2031)
Figure 42. Mexico Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Country (2020-2031)
Figure 46. Turkey Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Targeted Drug ROS1 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Roche Revenue Growth Rate in Targeted Drug ROS1 Inhibitors for NSCLC Business (2020-2025)
Figure 50. Pfizer Revenue Growth Rate in Targeted Drug ROS1 Inhibitors for NSCLC Business (2020-2025)
Figure 51. Beacon Pharma Limited Revenue Growth Rate in Targeted Drug ROS1 Inhibitors for NSCLC Business (2020-2025)
Figure 52. Drug International Limted Revenue Growth Rate in Targeted Drug ROS1 Inhibitors for NSCLC Business (2020-2025)
Figure 53. Incepta Pharmaceuticals Revenue Growth Rate in Targeted Drug ROS1 Inhibitors for NSCLC Business (2020-2025)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit